Recent Advances in the Design and Development of Novel Negative Allosteric Modulators of mGlu5
- 29 April 2011
- journal article
- review article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 2 (8) , 411-432
Abstract
Negative allosteric modulators (NAMs) of metabotropic glutamate receptor subtype 5 (mGlu5) have remained attractive to researchers as potential therapies for a number of central nervous system related diseases, including anxiety, pain, gastresophageal reflux disease (GERD), addiction, Parkinson’s disease (PD), and fragile X syndrome (FXS). In addition to the many publications with supportive preclinical data with key tool molecules, recent positive reports from the clinic have bolstered the confidence in this approach. During the 2 year time span from 2009 through 2010, a number of new mGlu5 NAM chemotypes have been disclosed and discussed in the primary and patent literature. A summary of several efforts representing many diverse chemotypes are presented here, along with a discussion of representative structure–activity relationships (SAR) and synthetic approaches to the templates where possible.Keywords
This publication has 82 references indexed in Scilit:
- Structure–activity relationships in a novel series of 7-substituted-aryl quinolines and 5-substituted-aryl benzothiazoles at the metabotropic glutamate receptor subtype 5Bioorganic & Medicinal Chemistry, 2010
- The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on behavioural responses to nicotinePsychopharmacology, 2010
- Discovery and SAR of 6-substituted-4-anilinoquinazolines as non-competitive antagonists of mGlu5Bioorganic & Medicinal Chemistry Letters, 2009
- Metabotropic glutamate receptor 5 (mGluR5) antagonists attenuate cocaine priming- and cue-induced reinstatement of cocaine seekingBehavioural Brain Research, 2009
- Discovery and SAR of novel mGluR5 non-competitive antagonists not based on an MPEP chemotypeBioorganic & Medicinal Chemistry Letters, 2009
- Role of protein kinase C epsilon (PKCɛ) in the reduction of ethanol reinforcement due to mGluR5 antagonism in the nucleus accumbens shellPsychopharmacology, 2009
- Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: Unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffoldBioorganic & Medicinal Chemistry Letters, 2008
- Attenuation of cocaine self-administration in squirrel monkeys following repeated administration of the mGluR5 antagonist MPEP: comparison with dizocilpinePsychopharmacology, 2008
- Discovery of heterobicyclic templates for novel metabotropic glutamate receptor subtype 5 antagonistsBioorganic & Medicinal Chemistry Letters, 2007
- Design and synthesis of novel heterobiaryl amides as metabotropic glutamate receptor subtype 5 antagonistsBioorganic & Medicinal Chemistry Letters, 2007